EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Reduced risk of hepatocellular carcinoma in the use of fibrate as an add-on to statin: A retrospective population-based cohort study

Won Sohn, Sangmo Hong, Kyungdo Han, Cheol-Young Park

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.116094 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Won Sohn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Fibric Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHydroxymethylglutaryl-CoA Reductase InhibitorsFibric AcidsDyslipidemiasHumansMaleFemaleRetrospective StudiesMiddle AgedRepublic of KoreaIncidenceAgedRisk FactorsAdultDrug Therapy, CombinationRisk Assessment

Stichwörter der Autor:innen

FibrateHepatocellular carcinomaRiskStatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsFibric Acids

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Guri Hospital, Hanyang University, College of Medicine, Seoul, Republic of Korea.
  • Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address: cydoctor@skku.edu.

Zitieren

APA

Sohn, W., Hong, S., Han, K., & Park, C. Y. (2025). Reduced risk of hepatocellular carcinoma in the use of fibrate as an add-on to statin: A retrospective population-based cohort study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116094

Vancouver

Sohn W, Hong S, Han K, Park CY. Reduced risk of hepatocellular carcinoma in the use of fibrate as an add-on to statin: A retrospective population-based cohort study. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.116094

BibTeX
@article{Sohn2025,
  author = {Sohn, Won and Hong, Sangmo and Han, Kyungdo and Park, Cheol-Young},
  title = {Reduced risk of hepatocellular carcinoma in the use of fibrate as an add-on to statin: A retrospective population-based cohort study},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.116094}
}
Kostenlos starten →